Search PubMed⌕ Search

Biomedical subjects

R D Steele

Publications and source records attributed to R D Steele.

52 records · Page 3Linked to original sources

Effect of methionine on in vivo histidine metabolism in rats.

Experiments were conducted to examine the effects of methionine supplementation on histidine metabolism in rats. All animals were fed 10% casein diets with a methionine content of either 0.6 or 1.1%. Experiments in which the animals were fed their diets containing an additional 1% histidine ad libitum for at least 10 days revealed that methionine-supplemented animals had a 49% reduction of plasma histidine and an 80% reduction in urinary excretion of formiminoglutamic acid (FIGLU) on day 10. This effect was not observed on day 5. In subsequent experiments rats were fed the control or test diet ad libitum prior to receiving their diets, containing a histidine load, by force-feeding. When a 100-mg histidine load was given on day 5, 24-hour urinary FIGLU excretion was 83% lower in methionine-supplemented animals. When rats were force-fed a 75-mg [ring-2-14C]histidine load on day 10, those receiving supplemental methionine oxidized 21% more of the histidine label to 14CO2 and excreted 61% less of the dose as urinary FIGLU in 24 hours. The activities of histidase and urocanase were unaffected by the methionine supplement. The results suggest that dietary methionine supplementation enhances the in vivo catabolism of histidine by stimulating one-carbon metabolism. Delivery of the methionine supplement by ad libitum feeding requires at least 5 days for this effect to be achieved.

Animals↗

Characterization of alpha-keto acid transport across blood-brain barrier in rats.

The transport of keto acids, monocarboxylic acids, and ketone bodies was studied in barbiturate-anesthetized, adult male Sprague-Dawley rats. [1-14C]propionate and D-3-[3-14C]hydroxybutyrate were found to cross the blood-brain barrier with brain uptake indexes of 43.53 and 7.10%, respectively. Transport of both of these substrates was saturable, with the values of transport Km being 2.03 and 6.54 mM, respectively. A Ki of 0.68 mM was derived from competition data measuring the uptake of [1-14C]alpha-ketoisocaproate in the presence of unlabeled alpha-ketobutyrate. This finding and results from classical inhibition studies support competition for transport of keto acids for a common carrier. The brain uptake of [1-14C]propionate was significantly reduced by keto acids and ketone bodies and the transport of D-3-[3-14C]hydroxybutyrate was significantly inhibited by unlabeled monocarboxylic acids, keto acids, and acetoacetate. Evidence for competitive transport of alpha-keto acids, monocarboxylic acids, and ketone bodies is presented in the form of classical double-reciprocal inhibition plots and of labeled monocarboxylic acids and ketone bodies by an increasing concentration of unlabeled alpha-ketoisocaproate, the latter method yielding Ki values of 0.29 and 0.63 mM, respectively. The brain uptake of labeled propionate was inhibited by unlabeled D-3-hydroxybutyrate. A Ki of 6.43 mM, derived from this data, approximated the Km of transport of D-3-hydroxybutyrate, suggesting that ketone bodies and monocarboxylic acids compete for transport via the same carrier that is operative for keto acids.

Animals↗

Transaminative metabolism of alpha-amino-n-butyrate in rats.

alpha-Amino-n-butyrate metabolism was studied in a rt tissue homogenate system using L-[1-14C] alpha-amino-n-butyrate. Transamination was found to be the major route in the liver for the metabolism of L-alpha-amino-n-butyrate based on 44.8 mumoles/g/h of [1-14-C] alpha-ketobutyrate formed in the presence of pyruvate versus 1.2 mumoles/g/h without pyruvate. The pH optimum for the reaction was 9.2. The abilities of other alpha-keto acids to act as a cosubstrate relative to pyruvate were (%): pyruvate, 100; alpha-ketobutyrate, 80; alpha-keto-gamma-methiolbutyrate, 15; phenylpyruvate, 14; alpha-ketoglutarate, p-hydroxyphenylpyruvate and the alpha-keto analogs of the branched-chain amino acids, all less than 10. The apparent Km for alpha-amino-n-butyrate in the liver homogenate was approximately 38 mM and the Km for pyruvate was 5 mM. Kidney was found to have about twice the activity as liver. Activities in brain, heart, diaphragm, muscle and small intestine were negligible. With the exception of serine, no other added amino acids could compete effectively with alpha-amino-n-butyrate for transamination in the rat liver homogenate system. Activity in rat liver was inhibited by aminooxyacetic acid and cycloserine. These results indicate that alpha-amino-n-butyrate is metabolized primarily by a transaminase reaction with pyruvate which occurs almost exclusively in liver and kidney.

4-Aminobutyrate Transaminase↗

Role of 3-ethylthiopropionate in ethionine metabolism and toxicity in rats.

The potential role of the pathway for ethionine catabolism involving the intermediate formation of 3-ethylthiopropionate in the etiology of ethionine hepatotoxicity was studied in rats. Rats were fed diets containing graded levels of 3-ethyl-thiopropionate, an intermediate of this pathway, for three weeks. A dietary level as low as 0.4% was toxic to rats, resulting in depressed growth and food intake, decreased blood hemoglobin levels and darkened and enlarged spleens. All animals fed 3-ethylthiopropionate expired a volatile sulfur compound that was identified as ethanethiol by gas chromatography using both a general flame ionization detector and a sulfur specific flame photometric detector. Rats fed diets containing either 0.8% ethionine or 3-ethylthiopropionate exhibited an 80% decrease in body weight gain over a three-week period compared to controls. Spleens were markedly darkened and enlarged and spleen iron content was 6-fold and 1.5-fold higher than controls in 3-ethylthiopropionate-fed and ethionine-fed rats, respectively. Liver concentrations of reduced and total glutathione were 30% higher than controls in ethionine-fed rats. There results document the marked toxicity of 3-ethylthiopropionate and ethionine and suggest that this pathway for ethionine catabolism may be involved in some of the numerous reported metabolic aberrations as a result of acute or chronic ingestion of ethionine.

Animals↗

Enhancement of histidine and one-carbon metabolism in rats fed high levels of retinol.

Histidine metabolism was studied in rats fed 10% casein diets supplemented with 1000 IU of retinol/g concurrent with or previous to exposure to high levels of dietary histidine (1% or 2%). When a retinol-supplemented 10% casein + 1% histidine diet was fed ad libitum for 21 days, urinary excretion of formiminoglutamic acid (FIGLU) was decreased by 50-70% over the entire period and plasma histidine was reduced by 30-70% for 16 days compared to rats receiving 10% casein + 1% histidine with normal levels of retinol. Rats pretreated for 10 days with a 10% casein diet supplemented with high levels of retinol oxidized 30% more L-[ring-2-14C]histidine to 14CO2 and excreted 76% less of the administered dose as urinary FIGLU compared to control rats not pretreated with high levels of retinol. Depression in growth due to supplementation of a 10% casein diet with 1% histidine were also partially alleviated in rats that were first pretreated with retinol. Activities of histidase, urocanase, and formiminoglutamic acid formiminotransferase (FIGLU transferase) were unaffected by retinol supplementation. The results suggest that retinol supplementation enhances histidine catabolism by exerting a change on one-carbon metabolism.

Animals↗

Transport of alpha-keto analogues of amino acids across blood-brain barrier in rats.

The transport of 14C-labeled alpha-keto acids across the blood-brain barrier (BBB) was studied in rats anesthetized with sodium pentobarbital using a modification of a single-injection dual-isotope technique. alpha-Keto acids were found to cross the BBB via a saturable carrier-mediated transport system that may be specific based on lack of inhibition by glucose, isoleucine, and ketone bodies on the uptake of tracer levels of 14C-labeled alpha-keto acids. alpha-Ketobutyrate and alpha-keto-gamma-methiolbutyrate, both straight chain keto acids, and alpha-ketoisocaproate, a branched-chain keto acid, appeared to cross the barrier by a common carrier based on cross-inhibition studies. Aromatic keto acids had no effect on the uptake of tracer levels of these 14C-keto acids. The Km of transport of alpha-ketobutyrate, alpha-ketoisocaproate, and alpha-keto-gamma-methiolbutyrate, was 0.11, 0.60, and 0.33 mM, respectively. The corresponding Vmax was 15.7, 73.3, and 30.2 nmol . g-1 . min-1. Phenylpyruvate was found not to cross the BBB. Inhibition of brain uptake of alpha-keto acids by propionate and pyruvate, and not by DL-beta-hydroxybutyrate suggests that alpha-keto acids and monocarboxylic acids are transported either via a common system independent of ketone bodies or share an affinity with a monocarboxylic acid and an alpha-keto acid transport system.

Amino Acids↗

Effect of portacaval shunt on sulfur amino acid metabolism in rats.

Male rats were subjected to portacaval shunts (PCS). Postoperative growth curves were similar between PCS and sham-operated control animals, with complete recovery of preoperative body weight occurring within 7 days. PCS rats had 30% smaller livers and 39% larger spleens at autopsy. Total liver levels of reduced glutathione were decreased by 38% in PCS rats. Sulfur amino acid metabolism was studied 6 wk after PCS by injection of L-[methyl-14C]- or L-[1-14C]methionine with 14CO2 collection or by similarly administering L-[35S]methionine or L-[35S] cysteine and measuring 24-h urinary 35SO4, [35S]taurine, and total 35S. There were no significant differences in 14CO2 production over an 8-h period between PCS and sham rats. PCS rats excreted 31% more 35SO4 and 25% more total 35S when injected with 0.9 mmol of [35S]methionine and excreted 38% less [35S]taurine than controls when injected with [35S]-cysteine. These results indicate altered sulfur amino acid metabolism in PCS rats, an animal model of portal-systemic shunting.

Amino Acids, Sulfur↗

Effects of dietary 3-methylthiopropionate on metabolism, growth and hematopoiesis in the rat.

Rats were fed a basal diet supplemented with (2.57%) 3-methylthiopropionate (MTP) for 2 weeks. A marked depression in growth and food intake similar to that found in rats fed an equimolar level of methionine was observed. While supplemental glycine or serine alleviated the toxicity due to dietary methionine, similar levels added to the diets of rats fed MTP were without effect. The spleens of rats fed diets containing 2.57% MTP were grossly enlarged and darkened in comparison to spleens from control rats and histological examination of these spleens by light and transmission electron microscopy (TEM) revealed sequestration of large numbers of erythrocytes in the splenic sinusoids and red pulp similar to that seen in rats fed high levels of methionine. Marrow changes included increased numbers of erythroblastic islets and subtantial electron dense hemosiderin deposits in islet reticulum cells. Examination of peripheral blood erythrocytes by scanning electron microscopy revealed extensive variation in the size of the erythrocytes and the presence of large numbers of misshapen red cells in rats fed the diets containing MT. When viewed by TEM many erythrocytes had obvious membrane defects and remnants of cytoplasmic organellae. Many erythrocytes with reticulocyte morphology were present in the peripheral blood. This condition is characteristic of maturation arrest at the reticulocyte stage of development. The similarity of depression in growth and food intake and the identical abnormalities found in the spleens of rats fed high levels of MTP and methionine suggest that the transamination pathway of methionine catabolism may be important with respect to the toxicity of methionine. The ultrastructural changes noted in MTP-fed rats suggest a serious dysfunction of red cell hematopoiesis. The large numbers of defective and/or immature erythrocytes released from the marrow into the peripheral circulation, only to be later sequestered and destroyed in the spleen, is a reflection of a serious derangement.

Animals↗

Diet composition and surgical technique influence the postoperative recovery of portacaval shunted rats.

In a series of experiments, rats were subjected to end-to-side portacaval shunts using either suture or nonsuture surgical procedures. Rats were maintained on cereal-based or purified diets in pellet form. All rats recovered preoperative body weights within the experimental periods; however, recovery of preoperative body weight was influenced by surgical technique and diet composition. Portacaval shunted rats fed a cereal-based diet required a longer period of time (14 days) to reattain preoperative body weights when compared to portacaval shunted rats fed a purified diet (7 days). Once preoperative body weight was recovered, growth rates of portacaval shunted rats were parallel to those of sham-operated controls. Rats with a suture-portacaval shunt appeared most sensitive to the feeding of a cereal-based diet. All portacaval shunted rats and sham controls fed a purified diet regained preoperative body weights within 7 days after surgery. Sham controls fed either a cereal-based or purified diet recovered preoperative body weights within an average of 4 days. Suture-portacaval shunted rats consuming a pellet form cereal-based diet showed a low feed efficiency which could be reversed by feeding a pellet form purified diet. Rats subjected to a nonsuture glue-portacaval shunt and fed a cereal-based diet showed 50% lower feed efficiencies than did glue-portacaval shunted rats fed a purified diet. Portacaval shunted rats decreased their consumption of cereal-based diets but not of purified diets postoperatively.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗